Triazolam

Product manufactured by Unit Dose Services

Application Nr Approved Date Route Status External Links
NDA017892 1985-04-26 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Triazolam Is Indicated For The Short-Term Treatment Of Insomnia (generally 7–10 Days). Use For More Than 2–3 Weeks Requires Complete Reevaluation Of The Patient (see Warnings). Prescriptions For Triazolam Should Be Written For Short-Term Use (7–10 Days) And It Should Not Be Prescribed In Quantities Exceeding A 1-Month Supply.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Triazolam TRIAZOLAM ZINC2212

Comments